|
GORASP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.555900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.816100E-02 |
| Normal-vs-Stage2 |
5.555800E-01 |
| Normal-vs-Stage3 |
3.966400E-01 |
| Normal-vs-Stage4 |
1.460210E-01 |
| Stage1-vs-Stage2 |
4.006400E-01 |
| Stage1-vs-Stage3 |
2.465800E-01 |
| Stage1-vs-Stage4 |
9.020800E-01 |
| Stage2-vs-Stage3 |
9.918400E-01 |
| Stage2-vs-Stage4 |
5.849200E-01 |
| Stage3-vs-Stage4 |
4.848600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.101800E-01 |
| Normal-vs-AfricanAmerican |
3.509900E-02 |
| Normal-vs-Asian |
1.473800E-02 |
| Caucasian-vs-AfricanAmerican |
2.496800E-01 |
| Caucasian-vs-Asian |
7.625900E-02 |
| AfricanAmerican-vs-Asian |
8.687400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.978610E-01 |
| Normal-vs-Female |
5.728000E-02 |
| Male-vs-Female |
6.283600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.089800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.083240E-01 |
| Normal-vs-Age(61-80Yrs) |
7.633000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.201800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.656200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.433500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.021200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.007000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.183800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.017000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.668400E-01 |
| Classical-VS-Follicular |
1.277630E-03 |
| Classical-VS-Other |
4.398100E-02 |
| Classical-VS-Normal |
9.202200E-03 |
| Tall-VS-Follicular |
8.963600E-02 |
| Tall-VS-Other |
9.844400E-02 |
| Tall-VS-Normal |
1.107180E-01 |
| Follicular-VS-Other |
6.279400E-01 |
| Follicular-VS-Normal |
5.499400E-01 |
| Other-VS-Normal |
3.102600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.747000E-01 |
| Normal-vs-N1 |
7.364800E-01 |
| N0-vs-N1 |
8.446000E-01 |
|
|
